학술논문
Phase II trial evaluating olaparib maintenance in patients with metastatic castration resistant prostate cancer (mCRPC) after docetaxel treatment, reaching partial or stable response: SOGUG-IMANOL study.
Document Type
Article
Author
Source
Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, p168-168, 1p
Subject
Language
ISSN
0732183X